FFCP PHASE1:Hg19::chr19:852520..852529,+: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{{FFCP|DPIdataset= | {{FFCP | ||
|DHSsupport=supported | |||
|DPIdataset=robust | |||
|EntrezGene=1991 | |||
|GencodeV16b_All_Build2_RSEM10_CPAT_consensus=no_gencodeV16_or_build2_transcript | |||
|HGNC=3309 | |||
|TSSclassifier=strong | |||
|UniProt=P08246 | |||
|association_with_transcript=-369bp_to_D00187_5end | |||
|coexpression_cluster_id=C1310 | |||
|description=CAGE_peak_3_at_ELANE_5end | |||
|id=chr19:852520..852529,+ | |||
|ontology_enrichment_celltype=CL:0000763!3.38e-11!112;CL:0000049!3.38e-11!112;CL:0002032!2.27e-07!165;CL:0000837!2.27e-07!165;CL:0000037!4.87e-07!172;CL:0000566!4.87e-07!172 | |||
|ontology_enrichment_celltype_v019=CL:0002032;2.70e-40;1!CL:0000557;2.70e-40;1 | |||
|ontology_enrichment_celltype_v019_2= | |||
|ontology_enrichment_development_v019= | |||
|ontology_enrichment_disease=DOID:8692!1.58e-33!31;DOID:1240!1.42e-26!39;DOID:2531!3.21e-20!51;DOID:0060083!3.21e-20!51;DOID:225!2.66e-18!1;DOID:74!7.98e-10!2;DOID:0050686!4.21e-07!137 | |||
|ontology_enrichment_disease_v019=DOID:225;6.62e-41;1!DOID:74;3.11e-21;2!DOID:8692;4.78e-12;31!DOID:1287;2.53e-11;4!DOID:1240;4.45e-08;39 | |||
|ontology_enrichment_disease_v019_2=DOID:225,6.62e-41,1;DOID:74,3.11e-21,2;DOID:8692,2.68e-12,31;DOID:1287,2.53e-11,4;DOID:1240,6.08e-10,39;DOID:2531,8.80e-08,51;DOID:0060083,8.80e-08,51 | |||
|ontology_enrichment_uberon= | |||
|ontology_enrichment_uberon_v019= | |||
|ontology_enrichment_uberon_v019_2= | |||
|phase1_expression=0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.324621940274555,0,0,0.47003968731907,0,0,0,0,0.425846237690326,0,2.15068535015921,0.671028323677248,2.50273712567863,0.586164286206121,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.02314474045374,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,1.27746588066972,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0524545881349981,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,5.54796994409533,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0.0644578879735772,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0 | |||
|short_description=p3@ELANE | |||
}} |
Revision as of 20:08, 20 January 2014
Short description: | p3@ELANE |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_3_at_ELANE_5end |
Coexpression cluster: | C1310_myelodysplastic_acute_granulocyte_biphenotypic_CD14_anaplastic_medulloblastoma |
Association with transcript: | -369bp_to_D00187_5end |
EntrezGene: | ELANE |
HGNC: | 3309 |
UniProt: | P08246 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
syndrome | 6.62e-41 | 1 |
hematopoietic system disease | 3.11e-21 | 2 |
myeloid leukemia | 2.68e-12 | 31 |
cardiovascular system disease | 2.53e-11 | 4 |
leukemia | 6.08e-10 | 39 |
hematologic cancer | 8.80e-08 | 51 |
immune system cancer | 8.80e-08 | 51 |